PDB Short entry for 1EUD HEADER LIGASE 14-APR-00 1EUD TITLE CRYSTAL STRUCTURE OF PHOSPHORYLATED PIG HEART, GTP-SPECIFIC SUCCINYL- TITLE 2 COA SYNTHETASE COMPND MOL_ID: 1; COMPND 2 MOLECULE: SUCCINYL-COA SYNTHETASE, ALPHA CHAIN; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: SCS-ALPHA; COMPND 5 EC: 6.2.1.4; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: SUCCINYL-COA SYNTHETASE, BETA CHAIN; COMPND 9 CHAIN: B; COMPND 10 SYNONYM: SCS-BETA; COMPND 11 EC: 6.2.1.4; COMPND 12 ENGINEERED: YES; COMPND 13 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SUS SCROFA; SOURCE 3 ORGANISM_COMMON: PIG; SOURCE 4 ORGANISM_TAXID: 9823; SOURCE 5 TISSUE: HEART; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET-3B; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: SUS SCROFA; SOURCE 12 ORGANISM_COMMON: PIG; SOURCE 13 ORGANISM_TAXID: 9823; SOURCE 14 TISSUE: HEART; SOURCE 15 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 16 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 17 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 18 EXPRESSION_SYSTEM_PLASMID: PET-3B KEYWDS LIGASE, GTP-SPECIFIC, PHOSPHONOHISTIDINE EXPDTA X-RAY DIFFRACTION AUTHOR M.E.FRASER,M.N.G.JAMES,W.A.BRIDGER,W.T.WOLODKO REVDAT 5 03-NOV-21 1EUD 1 REMARK SEQADV LINK REVDAT 4 24-JUL-19 1EUD 1 REMARK LINK REVDAT 3 24-FEB-09 1EUD 1 VERSN REVDAT 2 01-APR-03 1EUD 1 JRNL REVDAT 1 27-JUL-00 1EUD 0 JRNL AUTH M.E.FRASER,M.N.JAMES,W.A.BRIDGER,W.T.WOLODKO JRNL TITL PHOSPHORYLATED AND DEPHOSPHORYLATED STRUCTURES OF PIG HEART, JRNL TITL 2 GTP-SPECIFIC SUCCINYL-COA SYNTHETASE. JRNL REF J.MOL.BIOL. V. 299 1325 2000 JRNL REFN ISSN 0022-2836 JRNL PMID 10873456 JRNL DOI 10.1006/JMBI.2000.3807 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 0.9 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 41.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 97.9 REMARK 3 NUMBER OF REFLECTIONS : 39063 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.156 REMARK 3 FREE R VALUE : 0.215 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 3935 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5252 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 10 REMARK 3 SOLVENT ATOMS : 188 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.018 REMARK 3 BOND ANGLES (DEGREES) : 1.900 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1EUD COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 26-APR-00. REMARK 100 THE DEPOSITION ID IS D_1000010900. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-MAR-95 REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 4 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PHOTON FACTORY REMARK 200 BEAMLINE : BL-6A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : DIFFRACTOMETER REMARK 200 DETECTOR MANUFACTURER : WEISSENBERG REMARK 200 INTENSITY-INTEGRATION SOFTWARE : WEIS REMARK 200 DATA SCALING SOFTWARE : WEIS, BIOMOL (KBRANI, KBAPLY) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 39063 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 41.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : 4.000 REMARK 200 R MERGE (I) : 0.08800 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.09 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.13 REMARK 200 COMPLETENESS FOR SHELL (%) : 92.6 REMARK 200 DATA REDUNDANCY IN SHELL : 3.00 REMARK 200 R MERGE FOR SHELL (I) : 0.35800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: TNT REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.21 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.29 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: SODIUM,POTASSIUM(1:3) PHOSPHATE, 2 REMARK 280 -MERCAPTOETHANOL, AMMONIUM SULFATE, MICRODIALYSIS, TEMPERATURE REMARK 280 294K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 41.13900 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL ASSEMBLY IS AN ALPHA, BETA-DIMER CONSTRUCTED REMARK 300 OF CHAINS A AND B. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4730 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 27720 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -54.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -4 REMARK 465 ALA A -3 REMARK 465 ILE A -2 REMARK 465 ARG A -1 REMARK 465 HIS A 0 REMARK 465 LYS B 395 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 CYS B 268 CB CYS B 268 SG -0.099 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 138 C - N - CA ANGL. DEV. = 9.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 47 112.86 -162.84 REMARK 500 PRO B 94 170.25 -55.40 REMARK 500 LEU B 262 -168.87 -125.77 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 396 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 397 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1EUC RELATED DB: PDB REMARK 900 1EUC IS CRYSTAL STRUCTURE OF DEPHOSPHORYLATED PIG HEART, GTP- REMARK 900 SPECIFIC SUCCINYL-COA SYNTHETASE REMARK 900 RELATED ID: 2SCU RELATED DB: PDB REMARK 900 2SCU IS PHOSPHORYLATED SUCCINYL-COA SYNTHETASE FROM E. COLI REMARK 900 RELATED ID: 1CQI RELATED DB: PDB REMARK 900 1CQI IS CRYSTAL STRUCTURE OF THE COMPLEX OF ADP AND MG2+ WITH REMARK 900 DEPHOSPHORYLATED E. COLI SUCCINYL-COA SYNTHETASE REMARK 900 RELATED ID: 1CQJ RELATED DB: PDB REMARK 900 1CQJ IS CRYSTAL STRUCTURE OF DEPHOSPHORYLATED E. COLI SUCCINYL-COA REMARK 900 SYNTHETASE DBREF 1EUD A -2 306 GB 2258465 AAB94003 25 333 DBREF 1EUD B 1 395 UNP P53590 SUCB2_PIG 23 417 SEQADV 1EUD MET A -4 GB 2258465 CLONING ARTIFACT SEQADV 1EUD ALA A -3 GB 2258465 CLONING ARTIFACT SEQADV 1EUD NEP A 259 GB 2258465 HIS 286 MODIFIED RESIDUE SEQADV 1EUD MET B 0 UNP P53590 CLONING ARTIFACT SEQADV 1EUD VAL B 1 UNP P53590 LEU 23 ENGINEERED MUTATION SEQADV 1EUD CME B 332 UNP P53590 CYS 354 MODIFIED RESIDUE SEQADV 1EUD CSS B 343 UNP P53590 CYS 365 MODIFIED RESIDUE SEQRES 1 A 311 MET ALA ILE ARG HIS CYS SER TYR THR ALA SER ARG LYS SEQRES 2 A 311 HIS LEU TYR VAL ASP LYS ASN THR LYS VAL ILE CYS GLN SEQRES 3 A 311 GLY PHE THR GLY LYS GLN GLY THR PHE HIS SER GLN GLN SEQRES 4 A 311 ALA LEU GLU TYR GLY THR ASN LEU VAL GLY GLY THR THR SEQRES 5 A 311 PRO GLY LYS GLY GLY LYS THR HIS LEU GLY LEU PRO VAL SEQRES 6 A 311 PHE ASN THR VAL LYS GLU ALA LYS GLU GLN THR GLY ALA SEQRES 7 A 311 THR ALA SER VAL ILE TYR VAL PRO PRO PRO PHE ALA ALA SEQRES 8 A 311 ALA ALA ILE ASN GLU ALA ILE ASP ALA GLU VAL PRO LEU SEQRES 9 A 311 VAL VAL CYS ILE THR GLU GLY ILE PRO GLN GLN ASP MET SEQRES 10 A 311 VAL ARG VAL LYS HIS ARG LEU LEU ARG GLN GLY LYS THR SEQRES 11 A 311 ARG LEU ILE GLY PRO ASN CYS PRO GLY VAL ILE ASN PRO SEQRES 12 A 311 GLY GLU CYS LYS ILE GLY ILE MET PRO GLY HIS ILE HIS SEQRES 13 A 311 LYS LYS GLY ARG ILE GLY ILE VAL SER ARG SER GLY THR SEQRES 14 A 311 LEU THR TYR GLU ALA VAL HIS GLN THR THR GLN VAL GLY SEQRES 15 A 311 LEU GLY GLN SER LEU CYS VAL GLY ILE GLY GLY ASP PRO SEQRES 16 A 311 PHE ASN GLY THR ASP PHE THR ASP CYS LEU GLU ILE PHE SEQRES 17 A 311 LEU ASN ASP PRO ALA THR GLU GLY ILE ILE LEU ILE GLY SEQRES 18 A 311 GLU ILE GLY GLY ASN ALA GLU GLU ASN ALA ALA GLU PHE SEQRES 19 A 311 LEU LYS GLN HIS ASN SER GLY PRO LYS SER LYS PRO VAL SEQRES 20 A 311 VAL SER PHE ILE ALA GLY LEU THR ALA PRO PRO GLY ARG SEQRES 21 A 311 ARG MET GLY NEP ALA GLY ALA ILE ILE ALA GLY GLY LYS SEQRES 22 A 311 GLY GLY ALA LYS GLU LYS ILE THR ALA LEU GLN SER ALA SEQRES 23 A 311 GLY VAL VAL VAL SER MET SER PRO ALA GLN LEU GLY THR SEQRES 24 A 311 THR ILE TYR LYS GLU PHE GLU LYS ARG LYS MET LEU SEQRES 1 B 396 MET VAL ASN LEU GLN GLU TYR GLN SER LYS LYS LEU MET SEQRES 2 B 396 SER ASP ASN GLY VAL LYS VAL GLN ARG PHE PHE VAL ALA SEQRES 3 B 396 ASP THR ALA ASN GLU ALA LEU GLU ALA ALA LYS ARG LEU SEQRES 4 B 396 ASN ALA LYS GLU ILE VAL LEU LYS ALA GLN ILE LEU ALA SEQRES 5 B 396 GLY GLY ARG GLY LYS GLY VAL PHE SER SER GLY LEU LYS SEQRES 6 B 396 GLY GLY VAL HIS LEU THR LYS ASP PRO GLU VAL VAL GLY SEQRES 7 B 396 GLN LEU ALA LYS GLN MET ILE GLY TYR ASN LEU ALA THR SEQRES 8 B 396 LYS GLN THR PRO LYS GLU GLY VAL LYS VAL ASN LYS VAL SEQRES 9 B 396 MET VAL ALA GLU ALA LEU ASP ILE SER ARG GLU THR TYR SEQRES 10 B 396 LEU ALA ILE LEU MET ASP ARG SER CYS ASN GLY PRO VAL SEQRES 11 B 396 LEU VAL GLY SER PRO GLN GLY GLY VAL ASP ILE GLU GLU SEQRES 12 B 396 VAL ALA ALA SER ASN PRO GLU LEU ILE PHE LYS GLU GLN SEQRES 13 B 396 ILE ASP ILE ILE GLU GLY ILE LYS ASP SER GLN ALA GLN SEQRES 14 B 396 ARG MET ALA GLU ASN LEU GLY PHE LEU GLY PRO LEU GLN SEQRES 15 B 396 ASN GLN ALA ALA ASP GLN ILE LYS LYS LEU TYR ASN LEU SEQRES 16 B 396 PHE LEU LYS ILE ASP ALA THR GLN VAL GLU VAL ASN PRO SEQRES 17 B 396 PHE GLY GLU THR PRO GLU GLY GLN VAL VAL CYS PHE ASP SEQRES 18 B 396 ALA LYS ILE ASN PHE ASP ASP ASN ALA GLU PHE ARG GLN SEQRES 19 B 396 LYS ASP ILE PHE ALA MET ASP ASP LYS SER GLU ASN GLU SEQRES 20 B 396 PRO ILE GLU ASN GLU ALA ALA LYS TYR ASP LEU LYS TYR SEQRES 21 B 396 ILE GLY LEU ASP GLY ASN ILE ALA CYS PHE VAL ASN GLY SEQRES 22 B 396 ALA GLY LEU ALA MET ALA THR CYS ASP ILE ILE PHE LEU SEQRES 23 B 396 ASN GLY GLY LYS PRO ALA ASN PHE LEU ASP LEU GLY GLY SEQRES 24 B 396 GLY VAL LYS GLU SER GLN VAL TYR GLN ALA PHE LYS LEU SEQRES 25 B 396 LEU THR ALA ASP PRO LYS VAL GLU ALA ILE LEU VAL ASN SEQRES 26 B 396 ILE PHE GLY GLY ILE VAL ASN CME ALA ILE ILE ALA ASN SEQRES 27 B 396 GLY ILE THR LYS ALA CSS ARG GLU LEU GLU LEU LYS VAL SEQRES 28 B 396 PRO LEU VAL VAL ARG LEU GLU GLY THR ASN VAL HIS GLU SEQRES 29 B 396 ALA GLN ASN ILE LEU THR ASN SER GLY LEU PRO ILE THR SEQRES 30 B 396 SER ALA VAL ASP LEU GLU ASP ALA ALA LYS LYS ALA VAL SEQRES 31 B 396 ALA SER VAL THR LYS LYS MODRES 1EUD NEP A 259 HIS N1-PHOSPHONOHISTIDINE MODRES 1EUD CME B 332 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE MODRES 1EUD CSS B 343 CYS S-MERCAPTOCYSTEINE HET NEP A 259 14 HET CME B 332 10 HET CSS B 343 7 HET SO4 B 396 5 HET SO4 B 397 5 HETNAM NEP N1-PHOSPHONOHISTIDINE HETNAM CME S,S-(2-HYDROXYETHYL)THIOCYSTEINE HETNAM CSS S-MERCAPTOCYSTEINE HETNAM SO4 SULFATE ION FORMUL 1 NEP C6 H10 N3 O5 P FORMUL 2 CME C5 H11 N O3 S2 FORMUL 2 CSS C3 H7 N O2 S2 FORMUL 3 SO4 2(O4 S 2-) FORMUL 5 HOH *188(H2 O) HELIX 1 1 SER A 2 TYR A 11 5 10 HELIX 2 2 GLY A 25 GLY A 39 1 15 HELIX 3 3 THR A 63 GLY A 72 1 10 HELIX 4 4 PRO A 81 ALA A 95 1 15 HELIX 5 5 PRO A 108 LEU A 120 1 13 HELIX 6 6 PRO A 147 HIS A 151 5 5 HELIX 7 7 GLY A 163 VAL A 176 1 14 HELIX 8 8 ASP A 195 ASP A 206 1 12 HELIX 9 9 ASN A 221 ASN A 234 1 14 HELIX 10 10 GLY A 270 ALA A 281 1 12 HELIX 11 11 SER A 288 ALA A 290 5 3 HELIX 12 12 GLN A 291 ARG A 303 1 13 HELIX 13 13 GLN B 4 ASP B 14 1 11 HELIX 14 14 THR B 27 ASN B 39 1 13 HELIX 15 15 GLY B 53 GLY B 57 5 5 HELIX 16 16 ASP B 72 GLN B 82 1 11 HELIX 17 17 ARG B 123 ASN B 126 5 4 HELIX 18 18 ASP B 139 ASN B 147 1 9 HELIX 19 19 PRO B 148 ILE B 151 5 4 HELIX 20 20 LYS B 163 LEU B 174 1 12 HELIX 21 21 LEU B 177 ILE B 198 1 22 HELIX 22 22 ASP B 227 ARG B 232 5 6 HELIX 23 23 GLN B 233 MET B 239 1 7 HELIX 24 24 GLU B 246 TYR B 255 1 10 HELIX 25 25 GLY B 272 ASN B 286 1 15 HELIX 26 26 LYS B 301 THR B 313 1 13 HELIX 27 27 ALA B 333 ALA B 342 1 10 HELIX 28 28 ASN B 360 ASN B 370 1 11 HELIX 29 29 ASP B 380 SER B 391 1 12 SHEET 1 A 7 THR A 54 HIS A 55 0 SHEET 2 A 7 LEU A 58 PHE A 61 -1 O LEU A 58 N HIS A 55 SHEET 3 A 7 ASN A 41 THR A 46 1 O GLY A 45 N PHE A 61 SHEET 4 A 7 LYS A 17 GLN A 21 1 N VAL A 18 O ASN A 41 SHEET 5 A 7 ALA A 75 ILE A 78 1 O ALA A 75 N ILE A 19 SHEET 6 A 7 LEU A 99 CYS A 102 1 O LEU A 99 N SER A 76 SHEET 7 A 7 ARG A 126 ILE A 128 1 O ARG A 126 N VAL A 100 SHEET 1 B 7 CYS A 141 GLY A 144 0 SHEET 2 B 7 GLY A 134 ASN A 137 -1 O VAL A 135 N ILE A 143 SHEET 3 B 7 GLN A 180 GLY A 185 -1 O CYS A 183 N ILE A 136 SHEET 4 B 7 LYS A 153 SER A 160 1 N GLY A 154 O GLN A 180 SHEET 5 B 7 GLY A 211 GLU A 217 1 O GLY A 211 N GLY A 157 SHEET 6 B 7 VAL A 242 ALA A 247 1 N VAL A 243 O ILE A 212 SHEET 7 B 7 VAL A 284 VAL A 285 1 N VAL A 284 O VAL A 242 SHEET 1 C 4 PHE B 22 ALA B 25 0 SHEET 2 C 4 VAL B 103 GLU B 107 -1 O VAL B 103 N ALA B 25 SHEET 3 C 4 ILE B 43 ALA B 47 -1 N VAL B 44 O ALA B 106 SHEET 4 C 4 VAL B 67 THR B 70 -1 O HIS B 68 N LEU B 45 SHEET 1 D 3 VAL B 58 PHE B 59 0 SHEET 2 D 3 ASN B 87 ALA B 89 -1 N ALA B 89 O VAL B 58 SHEET 3 D 3 VAL B 98 LYS B 99 -1 O VAL B 98 N LEU B 88 SHEET 1 E 5 PHE B 152 GLN B 155 0 SHEET 2 E 5 GLY B 127 SER B 133 -1 N LEU B 130 O GLU B 154 SHEET 3 E 5 ARG B 113 ASP B 122 -1 N TYR B 116 O SER B 133 SHEET 4 E 5 ALA B 200 THR B 211 -1 O THR B 201 N MET B 121 SHEET 5 E 5 GLN B 215 CYS B 218 -1 O GLN B 215 N THR B 211 SHEET 1 F 5 PHE B 152 GLN B 155 0 SHEET 2 F 5 GLY B 127 SER B 133 -1 N LEU B 130 O GLU B 154 SHEET 3 F 5 ARG B 113 ASP B 122 -1 N TYR B 116 O SER B 133 SHEET 4 F 5 ALA B 200 THR B 211 -1 O THR B 201 N MET B 121 SHEET 5 F 5 ALA B 221 PHE B 225 -1 O LYS B 222 N GLU B 204 SHEET 1 G 2 LYS B 258 GLY B 261 0 SHEET 2 G 2 ASN B 292 ASP B 295 -1 N PHE B 293 O ILE B 260 SHEET 1 H 4 ILE B 266 VAL B 270 0 SHEET 2 H 4 ALA B 320 PHE B 326 1 O ALA B 320 N ALA B 267 SHEET 3 H 4 LEU B 352 GLU B 357 1 N VAL B 353 O ILE B 321 SHEET 4 H 4 ILE B 375 SER B 377 1 O THR B 376 N VAL B 354 LINK C GLY A 258 N NEP A 259 1555 1555 1.33 LINK C NEP A 259 N ALA A 260 1555 1555 1.33 LINK C ASN B 331 N CME B 332 1555 1555 1.32 LINK C CME B 332 N ALA B 333 1555 1555 1.33 LINK C ALA B 342 N CSS B 343 1555 1555 1.32 LINK C CSS B 343 N ARG B 344 1555 1555 1.33 CISPEP 1 GLY A 129 PRO A 130 0 0.90 CISPEP 2 GLY A 236 PRO A 237 0 0.45 CISPEP 3 ASN B 206 PRO B 207 0 0.75 SITE 1 AC1 3 GLY B 52 GLY B 53 ARG B 54 SITE 1 AC2 5 GLY A 254 ARG A 255 ARG A 256 MET B 0 SITE 2 AC2 5 LYS B 258 CRYST1 86.907 82.278 50.017 90.00 104.37 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011507 0.000000 0.002948 0.00000 SCALE2 0.000000 0.012154 0.000000 0.00000 SCALE3 0.000000 0.000000 0.020639 0.00000